Agenda

• Introduction Dayton Reardan, Ph.D., VP of Regulatory Affairs

• Medical Need Emmanuel Mignot, M.D., Stanford University

• Efficacy William Houghton, M.D., COO, Medical Officer

• Polysomnographic Effects of Xyrem Jed Black, M.D., Stanford University

• Safety William Houghton, M.D., COO, Medical Officer

• Summary of Risks Versus Benefits William Houghton, M.D., COO, Medical Officer

11:00 a.m.

• Abuse Liability Robert Balster, Ph.D., Medical College of Virginia

• Risk Management Patti Engel, R.N., B.S.N., VP Marketing & Sales

Previous slide

Next slide

Back to first slide

View graphic version